| Long name: |
BCL2L14 Primary Polyclonal Antibody |
| Also known as: |
BCL2L14 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
BCL2L14 |
| Specificity: |
This antibody will detect BCL2L14 isoform 1 only, This is a highly specific antibody against BCL2L14 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
280-292/327 |
| Subcellular location: |
Cytoplasm |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BCL2L14 |
| Gene ID number: |
79370 |
| Swiss Prot: |
Q9BZR8 |
| Tested Applications: |
IF(IHC-P), IHC-P |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Plays a role in apoptosis |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
Apoptosis facilitator Bcl-2-like protein 14, Apoptosis regulator Bcl-G, BCL2L14, Bcl2-L-14, BCLG |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
BCL2L14 |
| Short name: |
BCL2L14 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
B-cell CLL/lymphoma 2-like 14 (apoptosis facilitator) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BCL2L14 and IDBG-20014 and ENSG00000121380 and 102724106, BCL2L14 and IDBG-639454 and ENSBTAG00000047225 and 508365, Bcl2l14 and IDBG-194016 and ENSMUSG00000030200 and 66813, Plasma membranes, protein kinase binding, this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006915 and apoptotic process and biological process this GO :0012505 and endomembrane system and cellular component this GO :0016020 and membrane and cellular component this GO :0019901 and protein kinase binding and molecular function this GO :0042981 and regulation of apoptotic process and biological process this GO :0043229 and intracellular organelle and cellular component this GO :2001238 and positive regulation of extrinsic apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0019901 : protein kinase binding, this GO :0019901 : protein kinase binding, 79370, BCL2-like 14 (apoptosis facilitator) |
| Identity: |
16657 |
| Gene: |
BCL2L14 |
More about : BCL2L14 |
| Long gene name: |
BCL2 like 14 |
| Synonyms gene name: |
BCL2-like 14 (apoptosis facilitator) |
| Synonyms: |
BCLG BCL-G |
| Locus: |
12p13, 2 |
| Discovery year: |
2004-02-09 |
| GenBank acession: |
AF281254 |
| Entrez gene record: |
79370 |
| Pubmed identfication: |
11054413 |
| RefSeq identity: |
NM_030766 |
| Classification: |
BCL2 family |
| Havana BLAST/BLAT: |
OTTHUMG00000159528 |